Mirati Therapeutics Inc

NASDAQ:MRTX   3:59:51 PM EDT
82.09
-4.61 (-5.32%)
Earnings Announcements

Mirati Therapeutics Reports Second Quarter 2022 Financial Results And Recent Corporate Updates

Published: 08/03/2022 21:41 GMT
Mirati Therapeutics Inc (MRTX) - Mirati Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Updates.
Q2 Loss per Share $3.18.
Q2 Earnings per Share View $-3.49 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Total Revenue $5.4 Million.
Q2 Revenue View $345000.00 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.53 Million
Adjusted EPS is expected to be -$3.50

Next Quarter Revenue Guidance is expected to be $2.58 Million
Next Quarter EPS Guidance is expected to be -$3.70

More details on our Analysts Page.